Literature DB >> 2768784

Deficiency of carnitine palmitoyltransferase I.

J P Bonnefont1, R Haas, J Wolff, L P Thuy, R Buchta, J E Carroll, J M Saudubray, F Demaugre, W L Nyhan.   

Abstract

Defective activity of carnitine palmitoyltransferase I was demonstrated in fibroblasts derived from a patient with hypoketotic hypoglycemia. The level of activity observed was approximately 10% of the control mean. Oxidation of palmitate by intact fibroblasts was reduced to 5% of control values. The patient presented at age 14 months with seizures and was found to have marked hypoglycemia and no ketones in the urine. In response to fasting, she developed hypoglycemia, but the curves for acetoacetate and 3-hydroxybutyrate were flat. Administration of medium-chain triglycerides relieved the hypoglycemia and generated a brisk ketogenesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2768784     DOI: 10.1177/088307388900400310

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  7 in total

1.  Elevated plasma carnitine in the hepatic form of carnitine palmitoyltransferase-1 deficiency.

Authors:  C A Stanley; F Sunaryo; D E Hale; J P Bonnefont; F Demaugre; J M Saudubray
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Cloning and characterization of murine carnitine acetyltransferase: evidence for a requirement during cell cycle progression.

Authors:  S Brunner; K Kramar; D T Denhardt; R Hofbauer
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

Review 3.  Fatty acid metabolism by the osteoblast.

Authors:  Priyanka Kushwaha; Michael J Wolfgang; Ryan C Riddle
Journal:  Bone       Date:  2017-08-31       Impact factor: 4.398

4.  Cloning, sequencing and heterologous expression of a cDNA encoding pigeon liver carnitine acetyltransferase.

Authors:  T M Johnson; H P Kocher; R C Anderson; G M Nemecek
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

5.  Over-expression and characterization of active recombinant rat liver carnitine palmitoyltransferase II using baculovirus.

Authors:  T M Johnson; W R Mann; C J Dragland; R C Anderson; G M Nemecek; P A Bell
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

6.  Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies.

Authors:  F Demaugre; J P Bonnefont; M Colonna; C Cepanec; J P Leroux; J M Saudubray
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

7.  The use of nutritional supplements to induce ketosis and reduce symptoms associated with keto-induction: a narrative review.

Authors:  Cliff J D C Harvey; Grant M Schofield; Micalla Williden
Journal:  PeerJ       Date:  2018-03-16       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.